Report

Global Slip trip syringe Market Size study, by Capacity (1-3 ml, 3-6 ml, 6-10ml, more than 10 ml) by End user (Hospital, medical institutes, clinical and research labs, blood banks, others) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Global Slip trip syringe Market to reach USD XX billion by 2027.Global Slip trip syringe Market is valued approximately at USD Xx billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. slip trip syringe. are the syringe which replaces the needle over it and make it easy for installation and removal. Slip tip syringe provide scaling meter for accurate dosage. Growing incidence of chronic disease across the world such as tuberculosis , diabetes, covid 19 and innovation in the technology in heath sector and specifically slip trip has led the adoption of slip trip syringe across the forecasted period. For instance, US government has invested $138 million with the syringe manufacturer and increased the production of syringe for corona virus vaccine by the end of 2020. However, various chronic diseases can be infected just because of needle stick injuries and high cost of research and development over safety syringe may hinder the growth of slip trip syringe globally would impedes the growth of the market over the forecast period of 2021-2027. Also, with the increasing prevalence of diseases, the adoption & demand for Slip trip syringe is likely to increase the market growth during the forecast period.

The regional analysis of global Slip trip syringe market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of Slip trip syringe and other medical equipment coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as rising disposable income, rising incidences of diseases and improving healthcare infrastructure would create lucrative growth prospects for the Slip trip syringe market across Asia-Pacific region.

Major market player included in this report are:
Nipro corporation
Air-tite products co. Inc
Sino mould
Famacy group
Cardinal health
Grovet B.v
Goldenwell group
Becton
Dickinson and company
Merck KGaA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Capacity :
1-3 ml
3-6 ml
6-10 ml
More than 10 ml

By End user:
Hospitals
Medical institute
Clinical and research labs
Blood banks
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Slip trip syringe Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors